Market entry into the German healthcare sector involves many challenges and risks. The assessment of market potential, risk evaluations and corresponding studies regarding the applicability of new products by users are among our core competencies. With our expertise, we shorten the time to market for our clients from the industrial, medtech and pharmaceutical sectors.
There is interest from many companies in entering the German healthcare market. Often, the necessary understanding of the needs of the service providers and the regulatory framework is lacking. In-depth market knowledge is required, especially around reimbursement structures. A good product alone is not enough to gain a foothold in the German healthcare system. Restrictive access and the lengthy process regularly ensure that companies do not dare to enter the market or fail to do so.
With our market know-how and the experience gained from many years of cooperation with service providers, payers and investors, we are happy to provide support.
Since Oberender AG was founded, we have regularly served customers from the MedTech and Pharma sectors. As a result, we have built up a high level of expertise that enables us to simplify cumbersome paths and shorten lengthy market entry procedures.
We understand both the service delivery side as well as the payer and investor side and help to bring them together with our clients’ ideas. We are well aware of the challenges of market access in the German healthcare system. Our experience also relates to value concepts and alternative approaches.
To get off to a successful start in the German healthcare sector, you need an accurate assessment of market potential. We provide sound assessments of products in practical use for users and support in communicating with payers.
We create optimal conditions for your market entry. If needed, our extensive network is available to you at any time.
As a trendsetter, we set the decisive impulses to bring healthcare organizations forward. Our competence units support decision-makers and experts with strategic projects and are creative when it comes to implementation.
We develop strategic analyzes for our customers in order to develop a future strategy that is economically sustainable and medically optimized.
With our wide range of expertise, we support a wide range of players in the healthcare sector. It is our aim not only to react to general conditions, but also to actively shape them.
Actively design your transactions in the healthcare, medtech or biotech sectors with our M&A competence team.